Kartos Therapeutics, Inc.   Report issue

For profit Phase 2
Founded: Redwood City CA United States (2017)

Organization Overview

First Clinical Trial
2018
NCT03662126
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kartos Therapeutics, Inc.